|Last Price||Today's Change||52-Week Range||Trading Volume|
|94.74||-0.92 (-0.96%)||66.85 - 96.15||5.7 million (Above Avg)|
Market data as of 3:59PM 08/27/14. Quotes are delayed by at least 15 min.
Celgene Corporation to Present at Investor Conferences in September
08/21/2014 8:30 AM ET
Clinical Study in the Journal of Clinical Oncology Reports Patients with Diffuse Large B-Cell Lymphoma Receiving Oral REVLIMID with Standard R-CHOP Achieved 98% Overall Response Rate and 80% Complete Response Rate
08/19/2014 7:30 AM ET